rxstat › Shortages › Aprepitant

Aprepitant (Emend Tri-Pack) shortage status

Discontinued

Source: Health Canada shortage reports · Updated Jul 16, 2026

Aprepitant products have been discontinued in Canada. See the reports below for which products and when.

An anti-nausea medication used to prevent nausea and vomiting caused by chemotherapy.

Products affected
0 / 1
Reports on file
3

Reports by product

The DIN is printed on your prescription label.

To be discontinued
EMEND TRI-PACK
80MG 125MG · CAPSULE KIT · MERCK CANADA INC
DIN 02298813
Resolved
EMEND TRI-PACK
125MG · CAPSULE KIT · MERCK CANADA INC
DIN 02298813 · ended Jul 15, 2022 · Delay in shipping of the drug.
Avoided
EMEND TRI-PACK
125MG 80MG · KIT CAPSULE · MERCK CANADA INC
DIN 02298813 · ended Aug 6, 2019 · Delay in shipping of the drug.

What's happening

One or more Aprepitant products have been permanently discontinued by their manufacturers. If your product is affected, ask your pharmacist about equivalent products still on the market.

Aprepitant is classified under “ANTIEMETICS AND ANTINAUSEANTS” (ATC A04AD).

Recent changes

Common questions

What is Aprepitant used for?

An anti-nausea medication used to prevent nausea and vomiting caused by chemotherapy.

When will Aprepitant be back in stock in Canada?

Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.

Why is Aprepitant in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Related drugs (antiemetics and antinauseants)

Granisetron Widespread shortage 2 of 2 reported products affected · est. return Aug 10, 2026 Fosaprepitant (Emend) Partial shortage 1 of 1 reported products affected · est. return Aug 14, 2026 Ondansetron (Zofran) Partial shortage 11 of 55 reported products affected · est. return Oct 30, 2026 Palonosetron (Aloxi) Partial shortage 1 of 2 reported products affected Aprepitant (Emend) Discontinued 0 of 2 reported products affected Nabilone (Cesamet) No current shortage

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.